Top Markets
#1 Tutorial Tutorial +33.20%
#2 Official Trump Official Trump +31.91%
#3 Siacoin Siacoin +22.47%
#4 Mubarak Mubarak +21.86%
#5 EXOD EXOD +18.93%
#6 Pump.fun Pump.fun +18.81%
#7 Unit Pump Unit Pump +18.81%
#8 MowCat MowCat +18.56%
#9 Wrapped STX (Velar) Wrapped STX (Velar) +18.54%
#10 Melania Meme Melania Meme +18.10%
Coin of the day
Tutorial Tutorial
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Abliva AB (publ) Abliva AB (publ)

Abliva AB (publ)

ABLI
Rang in aandelen #22998
Abliva AB (publ), a Swedish biopharmaceutical company founded in Lund in 2000,... Abliva AB (publ), a Swedish biopharmaceutical company founded in Lund in 2000, focuses on developing innovative therapeutic solutions for primary mitochondrial diseases. Its pipeline includes KL1333, currently in Phase 2/3 clinical trials for the long-term management of these conditions, and NV354, which is preparing for clinical studies targeting primary mitochondrial diseases specifically linked to Complex I deficiency. The company is also advancing NeuroSTAT through a Phase 1b/2a clinical study for the treatment of traumatic brain injury. Abliva maintains strategic partnerships with entities such as Isomerase, Yungjin Pharm, the University of Pennsylvania, Children's Hospital of Philadelphia, and Oroboros Instruments. The firm rebranded as Abliva AB (publ) in May 2020, having previously been known as NeuroVive Pharmaceutical AB (publ).
Aandeelprijs
$0.04959193
Laatst gesynchroniseerd: 2025-03-17
Marktkapitalisatie
$79.94M
Verandering (1 dag)
13.49%
Verandering (1 jaar)
0.00%
Land
SE
Handel Abliva AB (publ) (ABLI)

Categorie

Healthcare
P/S-ratio voor Abliva AB (publ) (ABLI)
P/S-ratio op 2026 TTM: 0
Volgens de meest recente financiële rapporten en aandelenkoers van Abliva AB (publ) is de huidige P/S-ratio (TTM) 0. Eind 2026 had het bedrijf een P/S-ratio van 0.
P/S-ratiohistoriek voor Abliva AB (publ) van 2026 tot 2026
P/S-ratio aan het einde van elk jaar
Jaar P/S-ratio Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
P/S-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/S-ratio Verschil in P/S-ratio Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH